NEW YORK (GenomeWeb News) – Epic Sciences today announced it has completed its Series B financing round raising $13 million.
Germany's Curetis has initiated a prospective clinical trial in the European Union for its Unyvero molecular testing system and P50 Pneumonia test cartridge, the company said in February.
By Ben Butkus
By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Curetis today announced its Series A financing round has increased by €9.6 million ($13.3 million) bringing the total amount raised in the round to €34.1 million.
According to founder and CEO Scott Tanner, the funds will go primarily toward ramping up production of CyTOF instruments, reagent production, and the establishment of a global sales and service team.
In Science this week: gene flow between ancient chimpanzees and bonobos, and more.
A startup wants to match customers to wine based on their DNA and one critic calls the idea 'silly,' Stat News reports.
Researchers trace the origins of brown rats using genetic analysis to China, the New York Times reports.
There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.